LECHLEIDER ROBERT (Chief Medical Officer) sold 77.7% of their position (55K shares) of IMMUNOME INC. on the open market
Open‑market sale worth $1.09M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/29/2026ACC: 0001997584-26-000002
Officer· Chief Medical Officer
Since Oct 2023
-55K
Net shares
Net seller
$1.09M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
55K acquired · 110K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+55K
Price / share
$8.73
Trade value
$480.15K
% of position
348.0%
6/25/2026
15.80K→70.81K
Common Stock
Direct
Shares
−40.58K
Price / share
$19.56
Trade value
$793.74K
% of position
57.3%
6/25/2026
70.81K→30.23K
Common Stock
Direct
Shares
−14.42K
Price / share
$20.66
Trade value
$297.92K
% of position
47.7%
6/25/2026
30.23K→15.80K
Total
Net shares
+0.00
Net value
-$611.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2026 | M · Option Exercise | +55K | $8.73 | $480.15K | 348.0% | 15.80K | 70.81K |
| Common Stock Direct | 6/25/2026 | S · Sale | −40.58K | $19.56 | $793.74K | 57.3% | 70.81K | 30.23K |
| Common Stock Direct | 6/25/2026 | S · Sale | −14.42K | $20.66 | $297.92K | 47.7% | 30.23K | 15.80K |
| Total | +0.00 | -$611.51K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
55K shares
Shares
−55K
Strike price
8.73
Held after
345K
Exercisable
—
6/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock55K shares | 6/25/2026 | M · Option Exercise | −55K | 8.73 | — | 345K |